Posted by Michael Wonder on 23 Mar 2021
Optellum receives FDA clearance for the world’s first AI-powered clinical decision support software for early lung cancer diagnosis
23 March 2021 - Virtual Nodule Clinic empowers clinicians to make optimal clinical decisions in early-stage lung cancer diagnosis and is now commercially available in the United States.
Optellum today announced it received FDA 510(k) clearance for its Virtual Nodule Clinic. This revolutionary product is an AI-powered clinical decision support software for pulmonologists and radiologists managing patients with small lesions in the lungs called nodules that could represent early-stage lung cancer. This is the first such application of AI decision support for early lung cancer diagnosis cleared by the FDA.
